DEFA14A: Soleno Therapeutics Sets Date for 2025 Annual Stockholder Meeting

Soleno Therapeutics will hold its annual stockholder meeting virtually on June 5, 2025, to elect directors and ratify the appointment of its accounting firm.

Summary

• Soleno Therapeutics will hold its 2025 Annual Meeting of Stockholders on June 5, 2025, at 8:00 a.m. PDT, conducted virtually.
• The meeting will address the election of two Class II directors to serve until the 2028 Annual Meeting.
• Stockholders will also vote to ratify the appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• Anish Bhatnagar, M.D. and William G. Harris are nominated as Class II directors.
• The Board of Directors recommends voting for the listed director nominees and for the ratification of the accounting firm appointment.
• Stockholders of record as of April 15, 2025, are entitled to vote.
• Proxy materials are available online, and stockholders can request paper or email copies.
• The deadline to request materials for timely delivery is May 18, 2025.
• Stockholders can vote online, virtually at the meeting, by telephone, or by mail.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, indicating normal corporate operations. The sentiment is neutral to slightly positive as it reflects the company's adherence to governance requirements.

Positives

• The company is holding its annual meeting to allow shareholders to participate in key decisions.
• Shareholders have multiple options for accessing proxy materials and voting, including online, phone, and mail.

Future Outlook

The document outlines the standard procedures for an upcoming annual meeting, with no specific forward-looking financial statements.

Industry Context

This is a standard proxy statement related to corporate governance, which is a routine part of operations for publicly traded companies.

Stakeholder Impact

• Shareholders have the opportunity to vote on key company matters.
• The election of directors and ratification of the accounting firm impact the company's governance and financial oversight.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold the Annual Meeting on June 5, 2025.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, Directors, Accounting Firm, Soleno Therapeutics, Vote